Antonio Giordano/X
Dec 9, 2024, 03:24
Antonio Giordano: Cycling through Innovation at ESMO Asia 24
Antonio Giordano, Breast Medical Oncologist at Harvard Medical School, shared a post on X:
“New way to target cell cycle. Cycling through Innovation ESMO – Eur. Oncology ESMOASIA24 with Drs. Lee and Naito.
Exciting new drugs to target CDK4, CDK2, and more in HR+/Her2- MBC.
Taking 2L PFS closer to 12 months and away from chemo.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 14, 2025, 06:56
Mar 14, 2025, 05:39
Mar 14, 2025, 05:30
Mar 14, 2025, 05:21
Mar 13, 2025, 14:26
Mar 13, 2025, 10:43
Mar 13, 2025, 10:14
Mar 13, 2025, 10:06
Mar 13, 2025, 09:32